ADAMTS13 and Genetic thrombotic microangiopathy: The observations of this study demonstrate a wider interest in ADAMTS13 as a prognostic marker in different clinical settings outside of thrombotic microangiopathies and, therefore, follow a scientific trend of new clinical ADAMTS13 characterization and alternative use [4,33,34].